Repairing tendon injuries with stem cells miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Background: The recent trend of pharmaceutical companies commercializing new objects as new drugs based on the findings of academic medical researchers, commonly categorizing them as “academic drug discovery” is increasingly gaining popularity in the pharmaceutical industry. Studies state that academic researchers based in universities have lower motivation to apply for patents. However, none of the studies evaluated the existence and extent of the “motivation for patent” in academic researchers, being lower than that of pharmaceutical companies. This study assesses two hypotheses; H1: academic medical researchers are less likely to believe that the patent system is necessary for pharmaceuticals, and thus have diminished interest in the commercialization of their research findings when compared to those in the pharmaceutical industry, H2: apprehension of the raison d’être of the patent system affects positive impressions on patents among academic medical researchers.
Insulin plays a critical role in the maturation, after injury, of immature olfactory sensory neurons. Applying insulin into the nasal passage could be developed as a therapy for injury caused by a host of issues.
Masanori Okada, a professor at Waseda University, left, and Ryuichi Ozawa, a professor at Jikei University School of Medicine, center, explain their request for the government to disclose documents related to their membership rejection to the Science Council of Japan in Tokyo on April 26. (Yu Kamata)
Six scholars have threatened legal action against the government if it refuses their information-disclosure request to find out why Prime Minister Yoshihide Suga rejected their memberships on the Science Council of Japan.
Most of their requests for documents on the reason and history behind their rejections were made on April 26.
They said they will consider filing a complaint or lawsuit if the government fails to provide the documents or blacks out information in them.
A street in Tokyo’s Ginza district is crowded on April 25, the first day of the third state of emergency period over the novel coronavirus. (Naoko Kawamura)
Japan surpassed the grim milestone of 10,000 deaths from COVID-19 on April 26, with 65 percent of the fatalities occurring this year, data showed.
Although the nation’s death rate during the pandemic is low compared with those in hard-hit Western countries, Japan is way behind other countries in East Asia and the Pacific region in containing the virus, according to the World Health Organization.
Japan’s accumulative death toll reached 10,025 on April 26, including deaths of patients who were aboard a cruise ship that docked off Yokohama early last year when the virus started to spread in the country, according to data compiled by The Asahi Shimbun.